{"id":870904,"date":"2025-08-05T08:58:57","date_gmt":"2025-08-05T12:58:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/"},"modified":"2025-08-05T08:58:57","modified_gmt":"2025-08-05T12:58:57","slug":"important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/","title":{"rendered":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PHILADELPHIA, Aug.  05, 2025  (GLOBE NEWSWIRE) &#8212; <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Centene Corporation (NYSE: CNC):<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n<p align=\"justify\">\n        <strong>If you purchased Centene (NYSE: CNC) shares prior to <\/strong><br \/>\n        <strong>December 12, 2024<\/strong><br \/>\n        <strong> and still hold shares today, <\/strong><br \/>\n        <strong>please visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHiA6Ghv8yVbdgIAmO3CkDy8dgG3HQbFA3AL8LzM8ijmYxNmM6a-KlpOHNuvZ2iNQQRpf9kemESBdU0MLaopAWoofGd2jUV9r2RFUH2SjQyuUsHx5DaFmuryrDm8CdFu0spJ783t7dI_Annp2-cWegxy_3cTJWqkmfA93mNNCL3JSoapQv0rW6uOa4dAQL8Dd4Y=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/centene-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, contact Joshua Grabar at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiVrDbs-htijJ9zZ02AYLZQUddH524Eb2UNzSYqLZV9Z0x4DXoAVE5XEeI92EPLv8lE=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, <\/strong><br \/>\n        <strong>or call us at 267-507-6085 to learn more. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>\n      <\/p>\n<p align=\"justify\">WHY? As alleged in a recently filed securities fraud class action complaint, Centene Corporation (NYSE: CNC) provided investors with material information concerning Centene\u2019s expected revenue guidance and adjusted diluted EPS for fiscal year 2025. Defendants\u2019 statements included, among other things, confidence in the Company\u2019s enrollment and morbidity rates, as well as strong retention rates in Centene\u2019s Medicare business.<\/p>\n<p align=\"justify\">The Complaint alleges that Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of Centene\u2019s enrollment and morbidity rates. The Complaint claims that such statements absent these material facts caused Plaintiff and other shareholders to purchase Centene\u2019s securities at artificially inflated prices.<\/p>\n<p align=\"justify\">\n        <strong>WHAT YOU CAN DO NOW:<\/strong><br \/>\n        <strong>If you purchased Centene (NYSE: CNC) shares prior to <\/strong><br \/>\n        <strong>December 12, 2024<\/strong><br \/>\n        <strong> and still hold shares today, <\/strong><br \/>\n        <strong>you are encouraged to visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHiA6Ghv8yVbdgIAmO3CkDy8dgG3HQbFA3AL8LzM8ijmY7iXrwbp35FE-8g0XNxEY09qRbTI7IlBBuakvKMO3iAxIT-GDEqaGi5D3YcRQsi17ujscBAZB57KuJcurgqWSnhghYzkUJNxjbOQafYJylIjgbij7LKHjjkBy9xVMYi-LF6EdRmuw06S_wB5i-2ej7k=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/centene-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, contact Joshua Grabar at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiXwxNl66g_zVJytbzMSMYAOdRqvm7UVMgWoIKEOuO6sPx74ci40g0iUfX-mWoQFlM8=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, <\/strong><br \/>\n        <strong>or call us at 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>If, alternatively, you purchased your shares between December 12, 2024, and June 30, 2025, you can participate in the class action. $CNC #Centene<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>DoubleVerify Holdings, Inc. (NYSE: DV):<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Grabar Law Office is investigating whether certain officers and directors of DoubleVerify Holdings, Inc. (NYSE: DV) breached their fiduciary duties owed to the company.<\/p>\n<p align=\"justify\">\n        <strong>If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and would like to learn more about the investigation and your rights, please visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHjFFy6xu9jpc3gE00y_uxpyt9fZWvGKz_eFvwRn4rINx1WznTiz83iQS9qLf-YfXkA7VvJl4tnX8MyLY90svd1XYYc-i3A4zsj1dN49itT4XvKms6KYlj_uIaEttQT91dyhp0zfSvSJrjwOhCTJW34Cxr3LTPD80-Dx3l-mXjOBxA6efsHm3LGPqazkiDSJwZg=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/doubleverify-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, <\/strong><br \/>\n        <strong>contact Joshua Grabar at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiX76V368S_Ussw3cSbMWWzoZqVtq09ph8RmjyHVWcXr898BUQWXgoNIfea0GQMJevo=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, or call us at 267-507-6085. You <\/strong><br \/>\n        <strong>can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Why?<\/strong> As alleged in an underlying securities fraud class action complaint, DoubleVerify (NYSE: DV), via certain of its officers, failed to disclose that: (a) DoubleVerify\u2019s customers were shifting their ad spending from open exchanges to closed platforms, where the Company\u2019s technological capabilities were limited and competed directly with native tools provided by platforms like Meta Platforms and Amazon; (b) DoubleVerify\u2019s ability to monetize on Activation Services, the Company\u2019s high-margin advertising optimization services segment, was limited because the development of its technology for closed platforms was significantly more expensive and time-consuming than disclosed to investors; (c) DoubleVerify\u2019s Activation Services in connection with certain closed platforms would take several years to monetize; (d) DoubleVerify\u2019s competitors were better positioned to incorporate AI into their offerings on closed platforms, which impaired DoubleVerify\u2019s ability to compete effectively and adversely impacted the Company\u2019s profits; (e) DoubleVerify systematically overbilled its customers for ad impressions served to declared bots operating out of known data center server farms; (f) DoubleVerify\u2019s risk disclosures were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities; and (g) as a result of the above, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially false and\/or misleading or lacked a reasonable basis.<\/p>\n<p align=\"justify\">\n        <strong>What You Can Do Now:<\/strong><br \/>\n        <strong>Current DoubleVerify (NYSE: DV) shareholders who have held DoubleVerify shares since prior to November 10, 2023,<\/strong><br \/>\n        <strong> can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever.<\/strong>\u00a0<strong>If you would like to learn more about this matter, you are encouraged to visit <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHjFFy6xu9jpc3gE00y_uxpyt9fZWvGKz_eFvwRn4rINx1WznTiz83iQS9qLf-YfXkBVUUw3LlZap4p_jxQCHEVGBh9ZSSL4bTehLusD1_M91xgB4iENV5AxsMmptiL09IBpBoCj6vR-52iL_G_BtSrOKz0hXPBR2iD4Fp018ylDsHFFt1jm5H4roEtk37Pj8Jo=\" rel=\"nofollow\" target=\"_blank\"><strong>https:\/\/grabarlaw.com\/the-latest\/doubleverify-shareholder-investigation\/<\/strong><\/a><strong>, contact Joshua H. Grabar at <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiUkli10mDoTrybsKJBtxtqzFBkdGCdC0LsBEwx2uTgvNMRi1Be2qc_6dxr1Rzgpf0o=\" rel=\"nofollow\" target=\"_blank\"><strong>jgrabar@grabarlaw.com<\/strong><\/a><strong>, or call 267-507-6085.<\/strong> $DV #DoubleVerify<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Napco Security Technologies, Inc. (NASDAQ: NSSC) Shareholder Class Action Survives Motion to Dismiss:<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>If you are a Current Napco Security Technologies, Inc. (NASDAQ: NSSC) shareholder who has held Napco shares since prior to November 7, 2022, you<\/strong><br \/>\n        <strong> can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Click here to join or learn more: <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHhMivLd4WTjI_Q3aSWBW-Rfdyd6IfaOTbCEF2xvFHugOtswf8AGt5kqC0iD1yMdEtBfHpNXegE9MywjeHHgQ5NGC8bKwu3kockbV7TdpCTNrMU5oemobtiv51aRZt6OtVlljqsbHYWfnUmzR4H6pDzD901RcWWFfg_NHNo39nxdPg==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/Napco-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, contact Joshua H. Grabar at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiWceAJZZHGidwIsoWyu4IpKsJg5pjA_5nZbrWT_2H2O6ArrR_ppkCUjHc06HxS0-U4=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, or call 267-507-6085.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Why?<\/strong><br \/>\n        <strong>Key allegations in a recently filed securities fraud class action complaint against the company and certain of its officers have survived a motion to dismiss.<\/strong>\u00a0That complaint alleges that Napco Security Technologies, Inc. (NASDAQ: NSSC), through certain of its officers and directors, made materially false and\/or misleading statements and\/or failed to disclose that: (1) Napco failed to address any material weaknesses with internal controls regarding cost of goods sold (&#8220;COGS&#8221;) and inventory; (2) Napco downplayed the severity of material weaknesses regarding their internal controls; (3) Napco\u2019s unaudited financial statements from September 30, 2022 to the present included \u201ccertain errors\u201d such as overstating inventory and understanding net COGS, resulting in overstated gross profit, operating income and net income for each period; (4) as a result, Napco would need to restate its previously filed unaudited financial statements for certain periods; and (5) as a result, Defendants\u2019 statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p align=\"justify\">\n        <strong>On April 11, 2025, the federal court determined that key allegations would survive Defendants\u2019 motion to dismiss the complaint. In so holding, the court determined <\/strong>\u201cPlaintiffs have adequately stated Exchange Act claims by pleading scienter [knowledge of wrongdoing] through defendants\u2019 unusual stock sales and by plausibly alleging loss causation between the corrective announcement and stock price drop. Plaintiffs have also stated Securities Act claims against Napco and the underwriter defendants.\u201d . . . \u201cTaking the well-pleaded facts as true, there is no question that plaintiffs have adequately pled scienter. First, the stock sales were highly unusual in timing and amount. As to amount, the total proceeds of over $108 million from stock sales by the officer defendants weigh in favor of a motive. . . . And the officer defendants sold hefty percentages of their holdings \u2013 48.5% for Soloway and 45.5% for Buchel.\u201d<\/p>\n<p align=\"justify\">\n        <strong>What To Do Now:<\/strong><br \/>\n        <strong>If you have held Napco shares since before November 7, 2022 and would like to learn more about this matter, please visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHhMivLd4WTjI_Q3aSWBW-Rfdyd6IfaOTbCEF2xvFHugOtgGjglKtSS3h7zf3g9cjYrFHGmjCO6h5W1TzMF12iLGU8el61ZZZbmbpDj5lmo7DupShHgtr4xQIgF5gbW3QP_SDDRVFdKFSBnW83pi3PsGb2gRqlwuNnteACL7f9-idw==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/Napco-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, contact Joshua H. Grabar at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiWb2ZD3b7wR39jPehQase2hTY0fNyULfYgs2Jft6T2Prm0z2nlWJaowEsuauPIYZm4=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, or call 267-507-6085. <\/strong><br \/>\n        <strong>You<\/strong><br \/>\n        <strong> can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong> $NSSC #Napco<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Treace Medical Concepts, Inc. (NASDAQ: TMCI)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to <\/strong><br \/>\n        <strong>May 8, 2023, you can<\/strong><br \/>\n        <strong> seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you<\/strong>. <strong>Visit <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHiOpdZKegDj_oSkos2Vh49v5erX5IIrJQy-TJtQqx-6446unKh2dQm0V2rIZrh5U6WYvbGUXMww0u1bIe2Zwk2OTnPdu-nINNeeltp3zTH-iLeCkN79zCn451MDQd7pNYC5X_UzXReVh10XqZ3jwG57JVje-Ao7H5bF-PRAVPazJZLy53kDrsTNWvuJO5ATGHw=\" rel=\"nofollow\" target=\"_blank\">https:\/\/grabarlaw.com\/the-latest\/treace-shareholder-investigation\/<\/a>,<strong> or <\/strong><strong>contact Joshua H. Grabar at\u00a0<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiWUveVQlhhiCe1GcJzj7nOvRJJ8D5b8PP0sougaskl5ycuQNU-pdc7lZRcnQGT1XZw=\" rel=\"nofollow\" target=\"_blank\">jgrabar@grabarlaw.com<\/a><strong>or call 267-507-6085 <\/strong><strong>to learn more.<\/strong><\/p>\n<p align=\"justify\">\n        <strong>Why?<\/strong> A recently filed securities class action complaint alleges that, Treace Medical Concepts, Inc. (NASDAQ: TMCI), via certain of its officers, made materially false and\/or misleading statements and failed to disclose adverse facts about the Company\u2019s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical\u2019s revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p align=\"justify\">\n        <strong>What You Can Do Now: <\/strong><br \/>\n        <strong>Current Treace shareholders who have held Treace shares since prior to May 8, 2023,<\/strong><br \/>\n        <strong> can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. <\/strong><br \/>\n        <strong>If you would like to learn more about this matter, you are encouraged to visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=33CTt1FwUqlz8-HxWnkh5ci0kbAh9KnXhLnEdLsmKHiOpdZKegDj_oSkos2Vh49v5erX5IIrJQy-TJtQqx-64yrn84rEorf_yfA61UQPgmHmAXV5uJvcADVscd3pIwvM0qxzs8OmDR0rSqTCVkNPYiLoISENiFNjmhY6_oHwuLcW9VxmisZ-jywdmOuqrwkrPJ5qm6VGYrz8OjPUgGK0kS2yphjZiysMYuzYWyymPQY=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/treace-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, contact us at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiV6m-9inORN_qm_yCC85o4E6uhC0kboHEwVVZJsq6toYm1aNv4MaZxq8KvLSPsUWsc=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>jgrabar@grabarlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, or call 267-507-6085.<\/strong> #Treace $TMCI<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B2x5GULWH1irOje-MfJkU9suBVjgyQ3nmQsgiBeP7uLjzYYw3ika90Dgp94tsOK2IWzzXaDzk39R-KFqHW0zokhtOK_83qfLVPlAvqDya69DGjegTwOHFhjI9brbS3FVxzR4_eZgb_S0NaX1qltWx9F7ATbF5D-U291FNRv40Jw=\" rel=\"nofollow\" target=\"_blank\">Attorney Advertising Disclaimer<\/a>\n      <\/p>\n<p align=\"justify\">Contact:<br \/>Joshua H. Grabar, Esq.<br \/>Grabar Law Office<br \/>One Liberty Place<br \/>1650 Market Street, Suite 3600<br \/>Philadelphia, PA 19103<br \/>Tel: 267-507-6085<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gFV3_J9LUkB5NbGbLRIy2_LLr1F20XIfFEFLs85pxiVIXiPvXfae5e8JM5majSpRDB1Ki-zef0J0OeRBn5mY7WDpm16IT-2JyH4fJh_CyHE=\" rel=\"nofollow\" target=\"_blank\">jgrabar@grabarlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTE1NGNhMjctNjZjYi00M2I0LThjNGItNmMzMmU2MGVkN2ZiLTEyMTI4MjMtMjAyNS0wOC0wNS1lbg==\/tiny\/Grabar-Law-Office.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Centene Corporation (NYSE: CNC): Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Centene (NYSE: CNC) shares prior to December 12, 2024 and still hold shares today, please visit https:\/\/grabarlaw.com\/the-latest\/centene-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call us at 267-507-6085 to learn more. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. WHY? As alleged in a recently filed securities fraud class action complaint, Centene Corporation (NYSE: CNC) provided &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870904","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Centene Corporation (NYSE: CNC): Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Centene (NYSE: CNC) shares prior to December 12, 2024 and still hold shares today, please visit https:\/\/grabarlaw.com\/the-latest\/centene-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call us at 267-507-6085 to learn more. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. WHY? As alleged in a recently filed securities fraud class action complaint, Centene Corporation (NYSE: CNC) provided &hellip; Continue reading &quot;Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T12:58:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf\",\"datePublished\":\"2025-08-05T12:58:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/\"},\"wordCount\":1491,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/\",\"name\":\"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\",\"datePublished\":\"2025-08-05T12:58:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/","og_locale":"en_US","og_type":"article","og_title":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Centene Corporation (NYSE: CNC): Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Centene (NYSE: CNC) shares prior to December 12, 2024 and still hold shares today, please visit https:\/\/grabarlaw.com\/the-latest\/centene-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call us at 267-507-6085 to learn more. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. WHY? As alleged in a recently filed securities fraud class action complaint, Centene Corporation (NYSE: CNC) provided &hellip; Continue reading \"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-05T12:58:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf","datePublished":"2025-08-05T12:58:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/"},"wordCount":1491,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/","name":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=","datePublished":"2025-08-05T12:58:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjM1MCM3MDgyMjIwIzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-centene-corporation-nyse-cnc-doubleverify-holdings-inc-nyse-dv-napco-security-technologies-inc-nasdaq-nssc-and-treace-medical-concepts-in\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870904"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870904\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}